Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Academic Licensing Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: FCL012
MIFTS: 51

Facial Paralysis

Categories: Neuronal diseases
Genes Variations Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Facial Paralysis

About this section

MalaCards integrated aliases for Facial Paralysis:

Name: Facial Paralysis 12 76 44 15 73
Facial Palsy 12 29 6
Bell Palsy 73

Classifications:

MalaCards categories:
Anatomical: Neuronal diseases
See all MalaCards categories (disease lists)
ICD10: 33


External Ids:

Disease Ontology 12 DOID:13934
ICD10 33 G51.0
MeSH 44 D005158
NCIt 50 C26769
UMLS 73 C0015469
Sources

Summaries for Facial Paralysis

About this section
MalaCards based summary : Facial Paralysis, also known as facial palsy, is related to bell's palsy and camurati-engelmann disease, and has symptoms including hemiplegia, ophthalmoplegia and oral manifestations. An important gene associated with Facial Paralysis is TUBB3 (Tubulin Beta 3 Class III), and among its related pathways/superpathways is N-cadherin signaling events. The drugs Methylprednisolone and Prednisolone have been mentioned in the context of this disorder. Affiliated tissues include bone, eye and skin, and related phenotypes are cellular and cardiovascular system

Wikipedia : 76 Facial nerve paralysis is a common problem that involves the paralysis of any structures innervated by... more...

Sources

Related Diseases for Facial Paralysis

About this section

Diseases related to Facial Paralysis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 143)
# Related Disease Score Top Affiliating Genes
1 bell's palsy 33.9 HOXB1 LIPN
2 camurati-engelmann disease 31.6 LRP5 TGFB1
3 acoustic neuroma 30.6 NF2 TGFB1
4 bone fracture 30.5 LRP5 TGFB1
5 hyperostosis 29.0 ANKH LRP5 TGFB1
6 facial palsy, congenital, with ptosis and velopharyngeal dysfunction 12.3
7 facial palsy, familial recurrent peripheral 12.2
8 recurrent peripheral facial palsy 12.1
9 congenital hereditary facial paralysis-variable hearing loss syndrome 12.0
10 deafness, conductive stapedial, with ear malformation and facial palsy 12.0
11 aortic arch interruption, facial palsy, and retinal coloboma 11.9
12 anotia facial palsy cardiac defect 11.9
13 melkersson-rosenthal syndrome 11.3
14 moebius syndrome 11.2
15 neurilemmoma 11.1
16 geniculate herpes zoster 11.1
17 facial paresis, hereditary congenital, 1 10.9
18 familial amyloidosis, finnish type 10.9
19 pontine tegmental cap dysplasia 10.7
20 charlie m syndrome 10.7
21 evans' syndrome 10.7 CD40LG TGFB1
22 giardiasis 10.6 CD40LG TGFB1
23 pustulosis palmaris et plantaris 10.6 CD40LG TGFB1
24 asthenopia 10.5 CADM1 LIPN
25 norwegian scabies 10.5 CD40LG TGFB1
26 poland syndrome 10.5 HOXA2 TUBB3
27 amyloid tumor 10.5 NF2 TUBB3
28 lattice corneal dystrophy 10.5 GSN TGFB1
29 craniodiaphyseal dysplasia 10.4 LRP5 TGFB1
30 paralytic squint 10.4 CADM1 TUBB3
31 premenstrual tension 10.2 LIPN LRP5
32 otitis media 10.2
33 sialolithiasis 10.2 LRP5 TGFB1
34 idiopathic neutropenia 10.1 CD40LG TGFB1
35 polyneuropathy 10.1 CD40LG GSN TUBB3
36 cranial nerve disease 10.1 LIPN MARVELD1 TUBB3
37 exotropia 10.1 TNNI3K TUBB3
38 ectropion 10.0
39 neuroma 10.0
40 herpes simplex 10.0
41 congenital ptosis 10.0 TNNI3K TUBB3
42 myoclonus and ataxia 10.0
43 parotitis 10.0
44 lymphoma 9.9
45 ptosis 9.9
46 mastoiditis 9.9
47 lagophthalmos 9.9
48 amyloidosis 9.9
49 hemifacial hyperplasia 9.9
50 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 9.9

Comorbidity relations with Facial Paralysis via Phenotypic Disease Network (PDN): (show all 11)


Acute Cystitis Epilepsy, Focal, with Speech Disorder and with or Without Mental Retardation
Exposure Keratitis Hypertension, Essential
Ischemic Heart Disease Mechanical Ectropion
Myoclonus and Ataxia Paralytic Lagophthalmos
Parotid Gland Cancer Swallowing Disorders
Transient Cerebral Ischemia

Graphical network of the top 20 diseases related to Facial Paralysis:



Diseases related to Facial Paralysis
Sources

Symptoms & Phenotypes for Facial Paralysis

About this section

UMLS symptoms related to Facial Paralysis:


hemiplegia, ophthalmoplegia, oral manifestations, sciatica, facial paresis, facial palsy, upper motor neuron, facial palsy, lower motor neuron, hemifacial paralysis, back pain, headache, flaccid muscle tone, pain, seizures, syncope, tremor, chronic pain, muscle weakness, vertigo/dizziness, generalized muscle weakness, sleeplessness

MGI Mouse Phenotypes related to Facial Paralysis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.13 ANKH CADM1 CD40LG GSN HOXA2 HOXB1
2 cardiovascular system MP:0005385 10 ANKH GSN HOXA2 LRP5 TGFB1 TNNI3K
3 immune system MP:0005387 9.92 HOXB1 LRP5 NF2 TGFB1 ANKH CADM1
4 endocrine/exocrine gland MP:0005379 9.91 CADM1 CD40LG GSN HOXB1 LRP5 NF2
5 mortality/aging MP:0010768 9.91 ANKH CD40LG GSN HOXA2 HOXB1 LRP5
6 craniofacial MP:0005382 9.88 ANKH HOXA2 HOXB1 LRP5 NF2 TGFB1
7 nervous system MP:0003631 9.81 CADM1 CD40LG GSN HOXA2 HOXB1 LRP5
8 respiratory system MP:0005388 9.5 ANKH GSN HOXA2 HOXB1 NF2 TGFB1
9 skeleton MP:0005390 9.23 NF2 TGFB1 ANKH CD40LG GSN HOXA2
Sources

Drugs & Therapeutics for Facial Paralysis

About this section

Drugs for Facial Paralysis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 79)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Not Applicable 83-43-2 6741
2
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Not Applicable 50-24-8 5755
3
Acyclovir Approved Phase 4,Not Applicable 59277-89-3 2022
4
Acetylcholine Approved Phase 4,Not Applicable 51-84-3 187
5
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
6 Antiemetics Phase 4,Phase 3,Not Applicable
7 Anti-Inflammatory Agents Phase 4,Phase 3,Not Applicable
8 Antineoplastic Agents, Hormonal Phase 4,Phase 3,Not Applicable
9 Autonomic Agents Phase 4,Phase 3,Not Applicable
10 Gastrointestinal Agents Phase 4,Phase 3,Not Applicable
11 glucocorticoids Phase 4,Phase 3,Not Applicable
12 Hormone Antagonists Phase 4,Phase 3,Not Applicable
13 Hormones Phase 4,Phase 3,Not Applicable
14 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Not Applicable
15 Methylprednisolone acetate Phase 4,Phase 3,Not Applicable
16 Methylprednisolone Hemisuccinate Phase 4,Phase 3,Not Applicable
17 Neuroprotective Agents Phase 4,Phase 3,Not Applicable
18 Peripheral Nervous System Agents Phase 4,Phase 3,Not Applicable
19 Prednisolone acetate Phase 4,Phase 3,Not Applicable
20 Prednisolone hemisuccinate Phase 4,Phase 3,Not Applicable
21 Prednisolone phosphate Phase 4,Phase 3,Not Applicable
22 Protective Agents Phase 4,Phase 3,Not Applicable
23 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Not Applicable
24 Antiviral Agents Phase 4,Not Applicable
25 valacyclovir Phase 4,Not Applicable
26 abobotulinumtoxinA Phase 4,Not Applicable
27 Botulinum Toxins Phase 4,Not Applicable
28 Botulinum Toxins, Type A Phase 4,Not Applicable
29 Cholinergic Agents Phase 4,Not Applicable
30 incobotulinumtoxinA Phase 4
31 Neuromuscular Agents Phase 4,Not Applicable
32 Neurotransmitter Agents Phase 4,Not Applicable
33 onabotulinumtoxinA Phase 4,Not Applicable
34 Vaccines Phase 4,Phase 3,Phase 2
35 Anesthetics Phase 4,Phase 3,Not Applicable
36 Anesthetics, Local Phase 4,Not Applicable
37 Anti-Arrhythmia Agents Phase 4,Phase 3
38 Central Nervous System Depressants Phase 4,Phase 3,Not Applicable
39 Diuretics, Potassium Sparing Phase 4
40 Sodium Channel Blockers Phase 4
41
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 3 7487-88-9 24083
42
Nicardipine Approved, Investigational Phase 3,Phase 1 55985-32-5 4474
43
Benzocaine Approved, Investigational Phase 3 1994-09-7, 94-09-7 2337
44
Diltiazem Approved, Investigational Phase 3 42399-41-7 39186
45
Labetalol Approved Phase 3 36894-69-6 3869
46 tannic acid Approved, Nutraceutical Phase 3
47 Urapidil Investigational Phase 3 34661-75-1
48 Analgesics Phase 3
49 Anticonvulsants Phase 3
50 calcium channel blockers Phase 3,Phase 1

Interventional clinical trials:

(show top 50) (show all 75)
# Name Status NCT ID Phase Drugs
1 Scandinavian Bell's Palsy Study Completed NCT00510263 Phase 4 Prednisolone + placebo;Valaciclovir + placebo;Prednisolone + valaciclovir;Placebo + placebo
2 Comparison of Three Botulinum Neuromodulators for Management of Facial Synkinesis Completed NCT03048383 Phase 4 OnabotulinumtoxinA Injectable Product;AbobotulinumtoxinA Injectable Product;Incobotulinumtoxin A Injectable Product
3 A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults Completed NCT01427309 Phase 4
4 Reinnervation of Facial Muscles After Lengthening Temporalis Myoplasty Terminated NCT01833221 Phase 4 injection of 1% lidocaine, 2mL for facial nerve block
5 Corticosteroids in Prevention of Facial Palsy After Cranial Base Surgery Completed NCT00438087 Phase 3 methylprednisolone
6 Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801 Completed NCT01604746 Phase 3
7 Field Administration of Stroke Therapy - Magnesium (FAST-MAG) Trial Completed NCT00059332 Phase 3 Magnesium Sulfate;Normal Saline
8 A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis Completed NCT02020889 Phase 3 Placebo
9 Intratympanic Steroid for Bell's Palsy Recruiting NCT03508440 Phase 2, Phase 3 Prednisone
10 Neuroprotectant for Hypertensive Intracerebral Hemorrhage Not yet recruiting NCT03546283 Phase 3 Placebos;Cattle Encephalon Glycoside and Ignotin
11 Multi-Year Study of Fluzone High-Dose Influenza Vaccine Compared With Fluzone® Vaccine in Adults Aged 65 Years and Older Terminated NCT00976027 Phase 3
12 Antihypertensive Treatment of Acute Cerebral Hemorrhage-II Terminated NCT01176565 Phase 3 Intravenous nicardipine hydrochloride
13 Quadrant Versus Superficial Parotidectomy Withdrawn NCT01607866 Phase 2, Phase 3
14 Comparison of Antibiotic Therapy Alone or Combined With Corticosteroids for the Treatment of Nontuberculous Mycobacterial Cervicofacial Lymphadenitis in Children: A Randomized Double-Blind Placebo-Controlled Study Withdrawn NCT01614977 Phase 3 Methylprednisoline
15 Palliative Re-irradiation for Progressive Diffuse Intrinsic Pontine Glioma (DIPG) in Children Completed NCT01777633 Phase 1, Phase 2
16 Seasonal Flu Vaccine in Adult Transplant Recipients Completed NCT01258023 Phase 2
17 Contrastim Stroke Trial Completed NCT01049802 Phase 1, Phase 2
18 A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma Completed NCT01153763 Phase 2 GSK2118436
19 A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes Recruiting NCT02785120 Phase 2 TF0023
20 Activated Protein C in Acute Stroke Trial Terminated NCT00533546 Phase 2 Activated Protein C
21 Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial Syndrome Terminated NCT01127503 Phase 2 Metyrosine;Placebo
22 Antihypertensive Treatment in Acute Cerebral Hemorrhage Completed NCT00415610 Phase 1 nicardipine
23 The Relationship Between Psychological Factors and Bell's Palsy Unknown status NCT01377766
24 Prednisone and Acupuncture for the Treatment of Facial Neuritis: a Multiple Center, CER in China Unknown status NCT01201642 Not Applicable Prednisolone
25 Two Different Surgical Methods of Blepharospasm Unknown status NCT02765113 Early Phase 1
26 Comparing the Behavior of the Cardiac Autonomic Regulation System During 24h in Patient Post Stroke and Controls Unknown status NCT02735616
27 Anthropometric Angular Measurement to Determine Muscle Tonus in Patients With Peripheral Facial Paralysis Completed NCT00903669
28 Microbiologic Findings of Acute Facial Palsy in Children Completed NCT01537952
29 Assessment of the Cross-face Nerve Graft in the Treatment of Facial Paralysis Completed NCT03006783
30 Steroid-Antiviral Treatment in Rehabilitation of Facial Palsy Completed NCT02328079 Not Applicable Steroids (Prednisolone) and Steroids plus Antiviral (Prednisolone + acyclovir)
31 Myofunctional Therapy in Facial Palsy Completed NCT00989209 Not Applicable Botulinum Toxin Type A
32 Randomized Controlled Trial of Acupuncture to Treat Bell's Palsy According to Different Stages Completed NCT00608660 Not Applicable
33 A Clinical Study on the Combined Magnetic and Oxygen Treatment for Bell's Palsy Completed NCT01686464 Not Applicable prednisone and valacyclovir treatments
34 Acupuncture With Deqi And Psychological Effects in Treatment of Bell's Palsy Completed NCT00685789 Not Applicable
35 Prednisone-Placebo vs Prednisone-Valacyclovir in Bell´s Palsy Completed NCT00561106 Not Applicable prednisone- valacyclovir;prednisone-placebo
36 Study of a New Technique to Improve the Symptoms of Orofacial Discomfort in Patients With Peripheral Facial Paralysis Completed NCT01327157 Not Applicable
37 Cognitive Function and Emotional Possessing in Bilateral Facial Palsy Completed NCT02179450
38 Complications in Parotid Surgery Completed NCT02486393
39 Retrospective Clinical Outcome of Parotid Tumor Surgery Completed NCT01983176
40 Post-parotidectomy Facial Paresis: Intraoperative and Postoperative Factors Completed NCT02527226 Not Applicable
41 Clinical Research Core Dental Screening Protocol Completed NCT00090818
42 Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of Age Completed NCT01985997
43 National Prospective and Comparative Study on the Mode of Delivery of Twins Completed NCT01987063
44 Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines Completed NCT02893878
45 Acute Recanalization of Thrombo-Embolic Ischemic Stroke With pREset (ARTESp) Completed NCT02437409
46 REACT AGAINST STROKE Completed NCT02846363
47 Ultrasound Evaluation of Tongue Movements in Speech and Swallowing Completed NCT00001167
48 Anterior Ultrasound-guided Cervical Plexus Block for Carotid Endarterectomy Completed NCT01640613
49 Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACELâ„¢ Vaccine Completed NCT00258882
50 Neuronal and Glial Biomarkers in Stroke Completed NCT02409043

Search NIH Clinical Center for Facial Paralysis

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: facial paralysis

Sources

Genetic Tests for Facial Paralysis

About this section

Genetic tests related to Facial Paralysis:

# Genetic test Affiliating Genes
1 Facial Palsy 29
Sources

Anatomical Context for Facial Paralysis

About this section

MalaCards organs/tissues related to Facial Paralysis:

41
Bone, Eye, Skin, Testes, Tongue, Breast, Heart
Sources

Publications for Facial Paralysis

About this section

Articles related to Facial Paralysis:

(show top 50) (show all 671)
# Title Authors Year
1
The Distal Stump of the Intramuscular Motor Branch of the Obturator Nerve Is Useful for the Reconstruction of Long-Standing Facial Paralysis Using a Double-Powered Free Gracilis Muscle Flap Transfer. ( 29381636 )
2018
2
Facial Paralysis Discussion and Debate. ( 29636148 )
2018
3
Societal Identification of Facial Paralysis and Paralysis Location. ( 29423522 )
2018
4
Speech and Communicative Participation in Patients With Facial Paralysis. ( 29955841 )
2018
5
Outcomes From Lateral Eyelid Coupling for Facial Paralysis Using the Modified Tarsoconjunctival Flap. ( 29621372 )
2018
6
Bilateral Post-Traumatic Facial Paralysis That Contains Longitudinal and Transverse Temporal Fracture. ( 29608481 )
2018
7
Functional outcomes assessment following free muscle transfer for dynamic reconstruction of facial paralysis: A literature review. ( 29628301 )
2018
8
Validation of the Clinician-Graded Electronic Facial Paralysis Assessment. ( 29596203 )
2018
9
Polyethylene glycol fusion associated with antioxidants: A new promise in the treatment of traumatic facial paralysis. ( 29522265 )
2018
10
Incomplete Facial Paralysis: The Use of the Ipsilateral Residual Facial Nerve as a Donor Nerve for Facial Reanimation. ( 29649064 )
2018
11
Comparison of symmetry after smile reconstruction for flaccid facial paralysis with combined fascia lata grafts and functional gracilis transfer for static suspension or gracilis transfer alone. ( 29603352 )
2018
12
The effects of lipoic acid and methylprednisolone on nerve healing in rats with facial paralysis<sup/>. ( 29310488 )
2018
13
Facial Paralysis in Patients With Hemifacial Microsomia: Frequency, Distribution, and Association With Other OMENS Abnormalities. ( 29771843 )
2018
14
Anxiety, depression, and hopelessness in patients before and after treatment for peripheral facial paralysis. ( 29940684 )
2018
15
Discussion: Incomplete Facial Paralysis: The Use of the Ipsilateral Residual Facial Nerve as a Donor Nerve for Facial Reanimation. ( 29952901 )
2018
16
Familial lower lip facial paralysis with asymmetric smile: Selective neurectomy of the cervical branch. ( 29728169 )
2018
17
Triple innervation for re-animation of recent facial paralysis. ( 29598895 )
2018
18
Hypoglossal-facial nerve &amp;quot;side&amp;quot;-to-side neurorrhaphy for facial paralysis resulting from closed temporal bone fractures. ( 29889081 )
2018
19
Quantifying Soft Tissue Shape and Symmetry: Patients with Cleft Lip/Palate and Facial Paralysis. ( 29707466 )
2018
20
Reply: Validation of the Clinician-Graded Electronic Facial Paralysis Assessment. ( 29596204 )
2018
21
Update on the Ophthalmic Management of Facial Paralysis. ( 29886125 )
2018
22
Comparison of Functional Results After Cross-Face Nerve Graft-, Spinal Accessory Nerve-, and Masseter Nerve-Innervated Gracilis for Facial Paralysis Reconstruction: The Chang Gung Experience. ( 29668505 )
2018
23
Familial progressive bilateral facial paralysis in Finnish type hereditary amyloidosis. ( 28578319 )
2017
24
Lip and Lower Lid Supporting Prosthetic Appliance: A Unique Approach of Treating Unilateral Facial Paralysis. ( 28658922 )
2017
25
Thread lifting: aA minimally invasive surgical technique for long-standing facial paralysis. ( 28567477 )
2017
26
Reliability of temporal bone high-resolution CT in patients with facial paralysis in temporal bone fracture. ( 29258690 )
2017
27
Minimal Nasolabial Incision Technique for Nasolabial Fold Modification in Patients With Facial Paralysis. ( 29049436 )
2017
28
Case analysis of temporal bone lesions with facial paralysis as main manifestation and literature review. ( 28826175 )
2017
29
Refractory Facial Paralysis: A Case Report. ( 29250758 )
2017
30
Facial Paralysis and Hearing Loss: A Rare Manifestation of Prostate Cancer Metastases. ( 28409073 )
2017
31
Facial paralysis due to Ramsay Hunt syndrome - A rare condition. ( 28614529 )
2017
32
What is the role of imaging in the evaluation of the patient presenting with unilateral facial paralysis? ( 28833220 )
2017
33
Restoration of orbicularis oculi muscle function in rabbits with peripheral facial paralysis via an implantable artificial facial nerve system. ( 29285055 )
2017
34
Ipsilateral facial paralysis and steroid acne. ( 28366909 )
2017
35
Simultaneous Reconstruction of Both Facial Paralysis and Temporomandibular Joint Ankylosis With a Composite Flap From Dorsum of Foot. ( 28891897 )
2017
36
Objective Outcomes of Minimally Invasive Temporalis Tendon Transfer for Prolonged Complete Facial Paralysis. ( 29026828 )
2017
37
Importance of Reporting Duration of Facial Paralysis in Studies of Emotion and Well-Being-Reply. ( 28617901 )
2017
38
Importance of Reporting Duration of Facial Paralysis in Studies of Emotion and Well-being. ( 28617900 )
2017
39
Outcome of a graduated minimally invasive facial reanimation in patients with facial paralysis. ( 28391532 )
2017
40
Facial Reanimation: Basic Surgical Tools and Creation of an Effective Toolbox for Treating Patients with Facial Paralysis: Part B. Nerve Transfer Combined with Cross-Facial Nerve Grafting in the Acute Facial Palsy Patient. ( 28234855 )
2017
41
Differential Reanimation of the Midface and Lower Face Using the Masseteric and Hypoglossal Nerves for Facial Paralysis. ( 29088397 )
2017
42
Partial Facial Paralysis as a Model for Prophylactic Botulinum Toxin Use for the Prevention of Facial Rhytides. ( 28498202 )
2017
43
Multivectored Superficial Muscular Aponeurotic System Suspension for Facial Paralysis. ( 28178098 )
2017
44
Validation of the Clinician-Graded Electronic Facial Paralysis Assessment. ( 28338582 )
2017
45
Surgical timing for facial paralysis after temporal bone trauma. ( 28302380 )
2017
46
Restoring facial symmetry through non-surgical cosmetic procedures after permanent facial paralysis: a case report. ( 28632885 )
2017
47
An unobtrusive computerized assessment framework for unilateral peripheral facial paralysis. ( 28541917 )
2017
48
Comparing Patient, Casual Observer, and Expert Perception of Permanent Unilateral Facial Paralysis. ( 28056121 )
2017
49
Efficient quantitative assessment of facial paralysis using iris segmentation and active contour-based key points detection with hybrid classifier. ( 26968938 )
2016
50
Iatrogenic Phenol Injury Causing Facial Paralysis With Tympanic Membrane and Ossicular Necrosis. ( 26927759 )
2016
Sources

Variations for Facial Paralysis

About this section

ClinVar genetic disease variations for Facial Paralysis:

6
# Gene Variation Type Significance SNP ID Assembly Location
1 46;XX;t(1;13)(q11.2;p11.2)dn Translocation Uncertain significance
Sources

Expression for Facial Paralysis

About this section
Search GEO for disease gene expression data for Facial Paralysis.
Sources

Pathways for Facial Paralysis

About this section

Pathways related to Facial Paralysis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
N-cadherin signaling events 1
10.14 GSN LRP5
Sources

GO Terms for Facial Paralysis

About this section

Biological processes related to Facial Paralysis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 negative regulation of osteoblast differentiation GO:0045668 9.46 HOXA2 LRP5
2 response to radiation GO:0009314 9.43 LRP5 TGFB1
3 oligodendrocyte development GO:0014003 9.4 GSN TGFB1
4 cell-cell junction organization GO:0045216 9.37 NF2 TGFB1
5 negative regulation of DNA replication GO:0008156 9.32 NF2 TGFB1
6 osteoblast development GO:0002076 9.26 HOXA2 LRP5
7 negative regulation of cell-cell adhesion GO:0022408 9.16 NF2 TGFB1
8 lens fiber cell differentiation GO:0070306 8.96 NF2 TGFB1
9 anterior/posterior pattern specification GO:0009952 8.8 HOXA2 HOXB1 LRP5
Sources

Sources for Facial Paralysis

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....